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Abstract: Since hyperphosphorylation of protein tau is a crucial event in Alzheimer’s disease, 
additional mechanisms besides the interplay of kinase and phosphatase activities are investigated, 
such as the effect of the peptidyl prolyl cis/trans isomerase Pin1. This isomerase was shown to bind 
and isomerize phosphorylated protein tau, thereby restoring the microtubule associated protein 
function of tau as well as promoting the dephosphorylation of the protein by the trans-dependent 
phosphatase PP2A. In this study we used models based on Saccharomyces cerevisiae to further 
elucidate the influence of Pin1 and its yeast ortholog Ess1 on tau phosphorylation and self-assembly. 
We could demonstrate that in yeast, a lack of Pin1 isomerase activity leads to an increase in 
phosphorylation of tau at Thr231, comparable to AD brain and consistent with earlier findings in 
other model organisms. However, we could also distinguish an effect by Pin1 on other residues of tau, 
i.e. Ser235 and Ser198/199/202. Furthermore, depletion of Pin1 isomerase activity results in reduced 
growth of the yeast cells, which is enhanced upon expression of tau. This suggests that the 
accumulation of hyperphosphorylated and aggregation-prone tau causes cytotoxicity in yeast. This 
study introduces yeast as a valuable model organism to characterize in detail the effect of Pin1 on the 
biochemical characteristics of protein tau, more specifically its phosphorylation and aggregation. 
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1. Introduction 
Tau protein is a microtubule associated protein (MAP), abundantly expressed in neurons of the 
central nervous system where it modulates the stability of axonal microtubules (MT). Binding to MT 
is dynamically controlled by reversible phosphorylation, as a result of the activities of different 
kinases and phosphatases. Abnormal phosphorylation of tau, however, results in aggregation of the 
protein and formation of paired helical filaments (PHF) and neurofibrillary tangles (NFT), major 
characteristics of many tauopathies including Alzheimer’s disease (AD). Since hyperphoshorylation 
is a crucial event in AD, kinase and phosphatase activities have been studied intensively [1]. In 
addition, the role of the peptidyl prolyl cis/trans isomerase (PPI) Pin1 has gained great interest. More 
specifically, Ser/Thr-Pro motifs in proteins can exist in two distinct conformations i.e. cis and trans, 
which slowly interconvert. However, the rate of conversion from the cis into the trans state can be 
significantly reduced by phosphorylation [2]. Hence, phosphorylation of protein tau on 
Thr231-Pro232 for example slows down the conversion from the cis to the trans state, ultimately 
making this tau residue a less favorable target for the trans-dependent phosphatase PP2A [3]. 
Furthermore, work with cis-specific antibodies showed that Thr231-phosphorylated tau in the 
cis-state, but not trans-state, is unable to promote MT assembly and is more prone to aggregation, 
besides being more resistant to dephosphorylation [4]. Pin1 recognizes specifically 
phospho-Ser/Thr-Pro motifs in proteins, like the AD-related phosphorylated proteins tau and  
APP [5,6], and facilitates the cis/trans interconversion of the proline amide bond [3,4,7]. 
Subsequently, Pin1 is able to restore the MAP function of phosphorylated tau [4,8,9] and to stimulate 
the dephosphorylation of the protein [3,4,9]. Other accumulating evidence demonstrates an 
association of the isomerase with AD. Pin1
−/−
 mice display an age-dependent full-blown tau 
pathology [9] whereas a decreased Pin1 expression/activity is reported in case of AD [4,9,10,11]. 
In the past, we already presented the value of Saccharomyces cerevisiae as a model organism to 
analyse the effect of phosphorylation, conformation and aggregation of protein tau [12,13,14]. To our 
knowledge, there are no S. cerevisiae based models so far to study in vivo the role of Pin1 in tau 
pathology. Yet, an important advantage of using yeast as model for this purpose is that yeast cells 
express a Pin1 homolog, namely Ess1, the sole and essential parvulin-like isomerase in this  
organism [15]. Without Ess1, cells undergo mitotic arrest and nuclear fragmentation. When human 
Pin1 is expressed, the lethal phenotype is suppressed [16], indicating that human Pin1 can 
functionally substitute Ess1 and that the function of these two isomerases is highly conserved in 
eukaryotes. 
Different strains are available with temperature sensitive ESS1 alleles, such as with the H164R 
mutation that affects the catalytic, PPIase domain of Ess1 [17]. This ts mutant of Ess1 maintains 
adequate isomerase activity at the permissive temperature (23 °C) but largely loses this activity at the 
restrictive temperature (37 °C). Moreover, the protein level of H164R mutant Ess1 seems to be 
reduced 2 to 10-fold under restricted circumstances. Consequently, the ess1
ts
 strain displays a slow 
growth phenotype at 37 °C and undergoes mitotic arrest and nuclear fragmentation within 4 to  
8 h [17]. Since isomerase activity can be reduced to an absolute minimum, the effect of deficiency of 
Pin1/Ess1 isomerase activity on the biochemical features of proteins can be studied in this particular 
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ess1
ts
 mutant strain.  
Here we describe the development of a yeast model, based on the ess1
ts
 (H164R) mutant strain, to 
examine the effect of Pin1 on the biochemical characteristics of protein tau. It was already shown that 
Pin1 promotes dephosphorylation of phospho-Thr231 [3,4] and, as more recently demonstrated, of the 
phospho-Ser202/phospho-Thr205-site, phospho-Thr212, phospho-Ser235 and phospho-Ser404 [7,18,19]. 
In this study, we noticed an elevated phosphorylation at Thr231, Ser235 and the Tau1 epitope 
(Ser198/199/202) due to the lack of Pin1 isomerase activity, confirming the studies mentioned above. 
Additionally, we observed an enhanced generation of inclusions in the ess1
ts
 strain. However, this 
was not associated with higher levels of sarkosyl insoluble tau (SinT), which is considered to 
represent mature aggregates of the protein. These results suggest that the inclusions in the Pin1 yeast 
model are rather accumulations of monomeric/oligomeric tau or possibly protofibrils. Furthermore, 
despite the absence of increased SinT levels, we noted tau related toxicity in the yeast cells with 
minimum isomerase activity. Combined, these data (i) emphasize the importance of elevated 
phosphorylation at specific phospho-sites in the mechanisms leading to tau toxicity and (ii) 
correspond to the hypothesis that the aberrantly phosphorylated monomeric tau or intermediate 
filaments of the protein are the cytotoxic species rather than the full-blown aggregates. 
2. Materials and Methods 
2.1. Yeast cultures and growth conditions 
In this study we used the Saccharomyces cerevisiae wild type W303-1A strain (MATa ura3-1 
leu2-3, 112 trp1-1 can1-100 ade2-1 his3-11, 15 [phi+]) and the ess1
ts
 strain, isogenic to the wild type 
W303-1A strain, with a temperature sensitive mutation in ESS1. The latter strain was a kind gift from 
the research group of Hanes [17]. Yeast cells were grown on YPD medium (2% bactopeptone, 1% 
yeast extract and 2% glucose) at respectively 30 °C and 23 °C in an orbital shaker at 220 rpm. 
Episomal plasmids with or without cDNA coding for human wild type Pin1 or human wild type tau 
(tau-2N/4R), inserted under the control of the strong constitutive TPI-promoter, were introduced into 
the yeast strains using a transformation technique based on Gietz et al. [20]. From that moment, the 
strains were grown at 30 °C or 23 °C on SC medium containing 0,19% yeast nitrogen base, 0.5% 
(NH4)2SO4, 30 mg/L adenine, 80 mg/L histidine, 30 mg/L of all other amino acids (leucine and/or the 
pyrimidine uracil were omitted to serve as a selection marker) and 2% glucose (SCD). In order to 
monitor the growth profiles of the strains, late exponential phase pre-cultures of at least three 
independent transformants were used to inoculate new cultures in the appropriate medium at a 
starting OD600 of 0.01. Growth of the cells at 23 °C and 37 °C was measured at 600 nm in 96-well 
plates every two hours for 60 hours using a Multiscan™ GO Microplate Spectrophotometer (Thermo 
Scientific™). For growth assays on solid medium a serial dilution of exponentially growing cells 
was made in SCD medium ranging from an OD600 of 1 to 0.0001. Of these dilutions, 5 µL was 
spotted on SCD agar plates, which were then incubated at 23 °C, 30 °C or 37 °C for at least 48 h. 
2.2. Survival plating and test for apoptotic markers 
Chronological aging experiments were performed as described [21,22], and representative aging 
experiments are shown.  
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Cultures were inoculated from fresh overnight cultures to reach approximately 2 × 10
6
 cells/mL. 
For chronological aging experiments aliquots were taken out to perform survival plating and tests for 
cell death markers at indicated time points. Tests for apoptotic (Annexin V staining) and necrotic (PI 
staining) markers, as well as markers for oxidative stress (DHE staining), were performed as 
described previously [23]. For quantifications using flow cytometry (BD FACSAria), 30,000 cells 
were evaluated and analyzed with BD FACSDiva software. Unstained and single stained samples 
served as controls for setting gates and proper compensation of respective channels (Annexin V 
detection, SL-1, FITC channel, exited by blue laser, PI detection, FL-6, PerCP-Cy5-5, exited by blue 
laser). 
2.3. Staining procedures and epifluorescence microscopy analysis 
Cells were applied to epifluorescence microscopy directly with the use of a small-band EGFP 
filter (Zeiss) on a Zeiss Axioskop microscope to monitor Annexin V positive cells, and a dsRed filter 
to monitor PI or ethidium positive cells. 
2.4. Denaturating gel electrophoresis 
Yeast cells were grown at 23 °C or 37 °C until an OD600 of 2.0 and harvested by short 
centrifugation, followed by boiling for 15 minutes in SDS sample buffer (50 mM TRIS pH 8.0; 2% 
SDS; 0.1% bromophenol blue, 10% glycerol, 10 mM β-mercapto-ethanol). Tris-glycine gels (7.5% or 
15%) were used to separate the proteins, which were transferred after separation to Immobilon-P 
membranes (Millipore, Billerica, MA). The primary and secondary antibodies chosen for this study are 
listed in Table 1. For detection, the ECL method was applied using a kit from Pierce Perbio (Belgium). 
Table 1. The primary and secondary antibodies chosen for this study. 
Antibody Specificity Source 
PolyTau Phosphorylation independent Innogenetics, Belgium 
AT180 Phospho-Thr231/Phospho-Ser235 Innogenetics, Belgium 
PT231 Phospho-Thr231 Calbiochem, Merck, Germany 
PS235 Phospho-Ser235 Abazyme, Needham, USA 
Tau1 Ser198/Ser199/Ser202 Chemicon, Temecula, CA 
AT270 Phospho-Thr181 Innogenetics, Belgium 
AD2 Phospho-Ser396/Phospho-Ser404 BIO-RAD, Hercules, CA 
Pin1 (H-123) aa 41-163 of Pin1 Santa Cruz Biotech. Inc. 
Adh2 anti-alcohol dehydrogenase Chemicon, Temecula, CA 
2.5. Sarkosyl insolubility assay 
45 mL of a yeast culture of OD600 of 2.0 was harvested by centrifugation and stored minimal 1 
hour at −80 °C. The pellet was resuspended in 2 mL TBS+ buffer (25 mM Tris pH 7.7; 150 mM NaCl; 
protease inhibitor cocktail; 0.5 mM PMSF; 1 mM EDTA; 0.2 mM Na3VO4; 20 mM NaF; 10 µM 
okadaic acid) and transferred to a falcon tube with glass beads. Cells were homogenized at 4 °C by 
vortexing for 1 minute followed by incubation on ice for 1 minute (20×). After adding 2 mL TBS
+
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buffer complemented with 1.6 M NaCl and 0.58 M sucrose, the samples were mixed briefly and put 
on ice during 5 minutes. Subsequently, the samples were centrifugated (30 minutes; 20,000 g; 4 °C) 
and Sarkosyl (N-lauroyl-sarkosine) (Sigma, Belgium) was added to the supernatant to a final 
concentration of 1% w/v. Following incubation at 4 °C during 1 hour and ultracentrifugation (40 
minutes; 150,000 g; 4 °C), the supernatant was stored at −20 °C. After washing the pellet with a mix 
of the two used TBS buffers complemented with Sarkosyl (ratio: 45/45/10), it was resuspended in 
pre-heated SDS sample buffer (50 mM TRIS pH 8.0; 2% SDS; 0.1% bromophenol blue, 10% 
glycerol, 10 mM β-mercapto-ethanol), boiled for 15 minutes at 95 °C and finally stored at −20 °C. 
2.6. In situ immunofluorescence 
Yeast cells were grown at the adequate temperature until an OD600 of 2.0 before fixing them 
with 4% formaldehyde for 15 minutes. After washing with a 0.1 M phosphate buffer solution (PB) (1 
M: 32.95 mL K2HPO4 1 M; 67.05 mL KH2PO4 1 M; pH 6.5), formaldehyde was again added to a 
final concentration of 4% for a second fixation (2 h). After a few washing steps, cells were 
resuspended in PB complemented with 1.2 M Sorbitol, 10 µL β-mercapto ethanol and 10 µL Lyticase 
(10 mg/mL) (Sigma, Belgium). Incubation at 30 °C during 1h resulted in spheroplasts, which were 
fixed upon a poly-lysine coated slide (Menzel-Gläser, Braunschweig, Germany), subsequently 
submerged in ice-cold methanol and acetone (6 minutes respectively 30 seconds at −20 °C) and 
blocked with PBST buffer (0.04 M K2HPO4; 0.01 M KH2PO4; 0.15 M NaCl; 0.1 g/100 mL NaN3; 
0.1% Tween20) and BSA (10 mg/mL) during 30 minutes at room temperature. The spheroplasts were 
incubated with a primary antibody overnight (at 4 °C) or during 2 hours (at room temperature). After 
washing with PBST buffer, suspensions of secondary antibodies (Alexa Fluor
®
 Dyes; Invitrogen, 
Belgium) were added for 2 h in the dark. After washing, the slides were completely dried and mounting 
medium (PPD) was applied for analysis with a fluorescence microscope, model DFC420C, Leica. 
3. Results 
3.1. Depletion of Ess1 leads to slow growth that can be restored by expression of human Pin1 
We constitutively expressed human wild type (WT) Pin1 from a high copy number plasmid in 
the W303-1A WT yeast strain and its isogenic ess1
ts
 strain and monitored the effect on growth. As 
illustrated in Figure 1A, the growth of the WT strain, with or without expression of human Pin1, was 
not affected by temperature. In contrast, the ess1
ts
 strain grown at restrictive temperature experienced 
a significant decrease in growth. Consistent with a study by Wu and co-workers [17], expression of 
human Pin1 restored the ess1
ts
 related growth phenotype. The expression of human Pin1 in the WT 
as well as ess1
ts
 strain was verified by Western blot analysis (Figure 3). 
3.2. Depletion of Ess1 leads to tau toxicity in yeast 
To study the interplay between Pin1 and protein tau in vivo, human WT tau was expressed alone 
or in combination with Pin1 in the WT strain and the ess1
ts
 strain. Growth analysis demonstrated that 
expression of the tau protein did not affect the growth of the WT yeast cells. Co-expression of Pin1 
did also not result in tau-related growth differences (Figure 1B). In contrast to the WT strain, 
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expression of tau in ess1
ts
 cells did cause significant changes in the growth properties of the strain. 
Besides a general decrease in growth at restrictive temperature, the ess1
ts
 strain experienced an 
additional growth defect due to expression of tau. Co-expression of Pin1 at restrictive temperature 
resorted the tau-related toxicity (Figure 1B). 
 
Figure 1. The effect of Ess1 depletion and tau expression on the growth of yeast cells. 
(A) The growth of WT and ess1ts cells with or without expression of Pin1 was monitored 
on solid glucose containing synthetic medium at 23 °C, 30 °C and 37 °C. (B) Growth 
curves of WT and ess1
ts
 cells transformed with an empty plasmid () or constructs 
allowing for expression of tau (), Pin1 and empty plasmid () or Pin1 and tau () 
were monitored on liquid glucose containing synthetic medium at 23 °C or 37 °C. The 
average growth of three independent transformants is shown. Error bars represent the 
standard deviation of three independent transformants. 
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3.3. Tau enhances cell death in aged ess1ts yeast cells 
First we measured the number of cells with increased reactive oxygen species (ROS) formation 
in the different ess1
ts
 strains. Quantification of ROS production was analyzed by the 
superoxide-driven conversion of non-fluorescent DHE into fluorescent ethidium. As shown in Figure 
2A and D, the presence of tau in the ess1
ts
 cells significantly increased the amount of ROS positive 
cells, even when grown at the permissive temperature. At restrictive temperature the effect of tau on  
 
Figure 2. Tau enhances cell death in aged ess1ts yeast cells. (A) Quantification of ROS 
ccumulation using DHE staining at different times during growth of ess1
ts
 cells at 23 °C 
transformed with an empty plasmid, or constructs allowing for expression of tau, Pin1 
and empty plasmid or Pin1 and tau. (B) Survival of the strains mentioned in (A) as 
determined by their ability to form colonies at 23 °C. (C) Quantification of the number of 
cells that display phosphatidylserine externalization or loss of membrane integrity using 
Annexin V / propidium iodide co-staining at 2 days of growth at 23 °C in the strains used 
in (A). (D) Fluorescence microscopic visualization of the cells expressing combinations 
of tau and Pin1 as indicated and stained with DHE (upper panels) or co-stained with 
Annexin V (green) and PI (red) (lower panels). All data represent the mean ± standard 
error (S.E.) of four independent transformants. 
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ROS production was less pronounced because the cells died quickly at 37 °C (data not shown). 
Co-expression of Pin1 counteracted the tau-induced ROS formation and this appeared to be 
independent of the temperature at which the cells were grown. Furthermore, we monitored the effect 
of tau on cell survival and cell death. As expected, the percentage of surviving cells correlated nicely 
with the ROS levels (Figure 2B). By co-staining with Annexin V and propidium iodide (PI), we 
discriminated between early apoptosis (Annexin V
+
), late apoptosis eventually leading to secondary 
necrosis (Annexin V
+
/PI
+
), and primary necrosis (PI
+
). As shown in Figure 2C and D, there was a 
strong increase in the level of late apoptotic cells (Annexin V
+
/PI
+
) in case of the ess1
ts
 strain 
expressing tau, already at the permissive temperature. Co-expression of Pin1 reduced the number of 
apoptotic cells and completely annihilated tau associated toxicity. 
3.4. Pin1/Ess1 affects the phosphorylation pattern of human tau expressed in yeast 
Next, we investigated via Western blot (WB) and immunodetection if the observed tau related 
toxicity in the ess1
ts
 cells could be linked to changes in phosphorylation of the protein or to 
differences in expression level of tau. As illustrated in Figure 3A, WB analysis, with the 
phosphorylation independent antibody Poly-Tau, of total protein extracts of WT cells expressing tau 
revealed distinct variants of the protein, ranging from 64 to 74 kDa. This was consistent with 
previous studies in yeast where the mixture of tau variants was shown to represent different 
phosphorylation forms of tau [13]. To specify the phosphorylation of the protein, a phospho-epitope 
scan was performed using different phospho-specific antibodies that recognize phosphorylated 
epitopes retrieved in Alzheimer brain. Apparently, protein tau expressed in WT yeast is 
phosphorylated in a similar way as AD tau since the protein yeast extracts reacted to every antibody 
used. Co-expression of Pin1 in WT cells did not change the phosphorylation of tau, nor did it 
significantly change the expression level of the protein (Figure 3B). The total protein level of tau in 
the yeast cells was gauged as the immuno-response of the Poly-Tau antibody in the extracts versus 
the immuno-response of an antibody towards Adh2, a typical yeast housekeeping gene. Regarding 
the ess1
ts
 strain, the phosphorylation pattern of tau resembled the phosphorylation pattern in the WT 
strain under permissive conditions, independent of co-expression of Pin1. However, when the ess1
ts 
cells were grown at restrictive temperature, a shift in electrophoretic mobility of tau was detected, 
while the expression level of tau did not significantly change (Figure 3B). In this case, the tau-variant 
with the highest electrophoretic mobility, i.e. the lowest degree of phosphorylation, decreased and a 
shift towards the variants with higher phosphorylation status occurred (Figure 3A). 
Using different phospho-specific antibodies, we obtained more detailed information on which 
epitopes of tau were actually affected by Pin1, Ess1 or both in yeast. As shown in Figure 3A, tau 
expressed in the ess1
ts
 strain grown at 37 °C revealed an upward shift in electrophoretic mobility 
when analysis was performed with the AT180, PT231 and PS235 antibodies (marked by open arrow). 
Expression of Pin1 counteracted this effect. Additionally, when WB analysis was performed with the 
antibody Tau1, the immunoreactivity of the protein extracts clearly decreased in case of minimal 
isomerase activity, implying a higher phosphorylation of tau at those particular residues.  
On the other hand, neither Ess1 nor Pin1 had an effect on the phosphorylation of tau at Thr181 
(AT270) and Ser396 and Ser404 (AD2) as illustrated in Figure 3A. 
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Figure 3. Phosphorylation pattern of tau in wild type and ess1
ts
 cells.  
(A) Representative Western blot analysis with indicated primary antibodies was 
performed on total protein extracts obtained from WT and ess1
ts
 strains, expressing tau 
with (+) or without (−) co-expression of Pin1. The cells were grown at 23 °C or 37 °C. 
Open arrows represent a change in the phosphorylation status of protein tau. To assess 
the expression of tau in the yeast strains, the endogenous alcohol dehydrogenase Adh2 
served as internal standard. Molecular weight markers are indicated on the right. (B) Bar 
diagram illustrating the total protein levels of tau expressed in the WT and ess1
ts
 strain, 
with or without co-expression of Pin1. To estimate the tau levels in the protein extracts, 
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the ratio was determined of the immuno-response towards the Poly-Tau antibody versus 
an antibody recognizing yeast Adh2. Quantification of the respective signals was 
performed using the VisionWorks
®
LS Analysis Software (UVP). Statistical analysis was 
done using GraphPad Prism 6. Based on a Kruskal-Wallis test no statistical significance 
could be noted between the four conditions within WT (p-value 0.059) or ess1
ts
 (p-value 
0.276) cells. 
3.5. The lack of isomerase activity does not influence aggregation of human tau expressed in yeast 
Next, we tested whether a lack of isomerase activity affects aggregation of tau in yeast as well. 
To this end, we performed a Sarkosyl insolubility assay. Sarkosyl or N-lauroyl-sarkosine is a 
detergent in which the solubility of a protein can be analyzed. The fraction of tau which is no longer 
soluble in 1% Sarkosyl (SinT; Sarkosyl insoluble fraction of tau) is considered as aggregated tau. 
Remarkably, the SinT levels of tau expressed in the ess1
ts
 strain do not change in case the cells are 
grown at restrictive temperature, nor do the levels vary with any statistical significance when Pin1 is 
co-expressed (Figure 4). 
 
Figure 4. Sarkosyl insolubility of tau in the ess1
ts
 strain with or without 
co-expression of Pin1. (A) Bar diagram showing the Sarkosyl insolubility of tau isolated 
from transformed ess1
ts
 cells with or without co-expression of Pin1 and grown at 23 °C 
(white bars) or 37 °C (black bars). Data are presented as percentages of SinT on total 
protein tau, determined with the phosphorylation independent antibody Poly-Tau on 
SDS-PAGE, and are the mean ± S.E. of two independent experiments. Statistical analysis 
was performed using GraphPad Prism 6. Based on a Kruskal-Wallis test no statistical 
significance could be stated between the four conditions (p-value 0.730). (B) 
Immunoblotting analysis of the Sarkosyl insoluble (SinT) and soluble (SolT) fractions of 
protein tau isolated from the ess1
ts
 strains, with the phosphorylation independent 
polyclonal antibody Poly-Tau. Representative Western blot results are shown. Note that 
more sarkosyl-insoluble extract was loaded to ensure immunodetection. 
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3.6. Depletion of Ess1 increases the inclusion formation of human tau expressed in yeast cells 
Finally, we investigated the localization and inclusion formation of tau in WT and ess1
ts
 cells 
using in situ immunofluorescence. In the WT cells, tau was found dispersed in the cytoplasm. Only a 
small number of cells displayed inclusions of tau, which did not change significantly by the presence 
of Pin1 (Figure 5A and B). In contrast, when the incubation temperature of the ess1
ts
 strain was 
switched from 23 °C to 37 °C, the localization of tau changed from diffuse distribution in the cytosol 
to small foci located at the periphery of the cell. Co-expression of Pin1 inhibited inclusion formation 
of tau and clearly maintained the diffuse cytosolic tau localization (p < 0.05), even under conditions 
of restricted Ess1 activity where the level of cells with tau inclusions was significantly increased (p < 
0.05) (Figure 5A and B). 
 
Figure 5. Visualisation of tau inclusions in WT and ess1
ts
 cells. (A) The percentage of 
inclusion positive cells was determined by the ratio of inclusion positive cells versus the 
total amount of cells with fluorescent signal. Data shown represent the mean ± S.E. of 
two independent experiments. The asterisks denote the statistical significance (*p < 0.05). 
(B) In situ immunofluorescence visualization of tau inclusions with the phosphorylation 
independent antibody Poly-Tau. 
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4. Discussion 
Studies in the field of AD, focused on deciphering the role of the peptidyl prolyl cis/trans 
isomerase Pin1, illustrated that this isomerase is able to restore the ability of phosphorylated tau to 
properly induce MT assembly and/or to promote the dephosphorylation of tau. In order to do so, the 
isomerase binds to phosphorylated Thr/Ser-Pro residues on protein tau [3,4,6-9,18,24,25]. Although 
the majority of these findings is based on in vitro assays or work in multifaceted models, like Pin1
−/−
 
mice, more straightforward eukaryotic models are finding their way into the research on Pin1, i.e. 
models based on the baker’s yeast S. cerevisiae [3,16,17]. Various mutants of Pin1 have been 
expressed in and purified from yeast strains, to determine in vitro which domains of the isomerase 
are important for the interaction with phospho-proteins like tau or to isomerize the 
phospho-Thr/Ser-Pro bonds. The isomerase-activity of Pin1 purified from yeast was confirmed in 
vitro as essential for regulating the dephosphorylation of tau by the phosphatase PP2A [3]. In a next 
step towards investigating the relationship between Pin1 and protein tau in vivo, we now expressed 
human protein tau in a S. cerevisiae strain where a temperature sensitive mutation was introduced in 
Ess1, the only and therefore, essential yeast homologue of human Pin1 [15]. Besides a decreased 
basal expression level of H164R-mutated Ess1, this mutant form of the yeast isomerase only 
maintains an adequate isomerase activity at permissive temperature. At restricted temperature, 
isomerase activity is reduced to an absolute minimum and leads to mitotic arrest, which can be 
reversed by expression of human Pin1 [16,17]. In our study, we developed a S. cerevisiae based 
model, founded on the ess1
ts
 mutant strain, to examine the effect of Pin1 on the biochemical 
characteristics of protein tau in vivo. We were able to document an effect of Pin1 on the 
phosphorylation of protein tau at the AT180 epitope, corresponding to many previous studies where 
Pin1 affects dephosphorylation of phospho-Thr231 [3,4,18,24,25]. Noteworthy, the AT180 antibody 
recognizes phospho-Thr231 as well as phospho-Ser235 and apparently, Pin1 also affects 
phosphorylation at the latter residue. This could be due to primed phosphorylation events, which 
have been shown to affect the MT binding ability of tau even more. Namely, GSK-3 phosphorylates 
Thr231, subsequent to phosphorylation of Ser235 [26]. By targeting phospho-Ser235, Pin1 could 
prevent phosphorylation of Thr231, thereby helping in preserving the interaction between tau and MT. 
Next to the AT180 epitope, we registered an effect by Pin1 on the phosphorylation of other sites, 
i.e. Ser198, Ser199 and/or Ser202 (Tau1 epitope). Phosphorylation at Ser199 was already shown to 
be modulated by Pin1 in hippocampal cultured neurons [27]. Nonetheless, in this particular study and 
another more recently published study [19], Pin1 also affected the phosphorylation at the AD2 
epitope, whereas we did not observe this effect, nor did other research groups [24,25]. Possibly, these 
contradictory results could be explained by differences in Pin1 activity in the various reports. We 
studied yeast cells without the involvement of external factors, whereas Bulbarelli and co-workers [27] 
treated cultured neuronal cells with A42 oligomers. Since up-regulation of Pin1 activity would be 
part of the self-defense mechanism of the cell in Alzheimer onset, the extra boost in Pin1 activity in 
the study by Bulbarelli could explain a supplementary effect on the phosphorylation of protein tau. 
With respect to Ser202, Pin1 was previously shown to affect the phosphorylation of this residue 
indirectly. Through a NMR spectroscopy study, phosphorylation of Thr231 was demonstrated to 
negatively influence the dephosphorylation of the AT8 epitope, which partially overlaps with the 
Tau1 epitope, i.e. phospho-Ser202 and phospho-Thr205. Thus, a priming dephosphorylation of 
phospho-Thr231 is required for efficient PP2A-mediated dephosphorylation of phospho-Ser202 and 
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phospho-Thr205, a process facilitated by Pin1 [18]. Since Pin1 isomerase activity is depleted in the 
ess1
ts
 strain, dephosphorylation of phospho-Ser202 could also be impaired. 
Increasing evidence suggests that the toxic species of protein tau are the hyperphosphorylated 
monomers, oligomers and/or intermediate tau filaments, rather than the NFT [28,29]. Actually, the 
NFT could be inert or neuro-protective [30,31,32]. The memory of mice improves in case of 
suppressing the expression of tau, despite of the continuous accumulation of NFT [33]. Accordingly, 
in yeast, events such as exposure to Fe
2+
 result in elevated SinT levels and increase in the amount of 
inclusions but this is not correlated with reduced growth of the cells [14]. On the contrary, as 
demonstrated in the current study, expression of protein tau in yeast in which Ess1 is inactivated does 
induce a growth defect without increased SinT levels. Interestingly, AT180 phosphorylation of tau is 
increased in cells with impaired Ess1 activity, whereas tau expressed in wild type yeast treated with 
Fe
2+
 displays decreased AT180 immunoreactivity [14]. These findings suggest that an altered 
phosphorylation status of tau is the culprit, not the elevation in SinT-levels. Most likely, these 
observations are linked to Pin1 activity. Dephosphorylation of tau at phospho-Thr231 by PP2A upon 
oxidative stress has previously been noted to significantly rely on Pin1 in neuronal cell cultures [24]. 
In our study, co-expression of Pin1 in the ess1
ts
 strain restores a normal phosphorylation level at the 
AT180 epitope, consistent with other studies where Pin1 promotes dephosphorylation of 
phospho-Thr231 [24,25]. Combined, this strengthens the hypothesis that Pin1 could represent a 
response of the cells to convert toxic tau accumulations into inert inclusions. One may even argue 
that Pin1 is actually needed for the self-assembly of tau into higher order filaments. In AD brain 
tissue, Pin1 has been found to co-localize with accumulations of phosphorylated tau [34], even in the 
most insoluble hyperphosphorylated tau fraction [10]. It is possible that the aggregated 
hyperphosphorylated tau sequesters the isomerase, but it might as well be that Pin1 binds to tau in 
order to form neuro-protective NFT. This would explain why SinT levels do not increase significantly 
when isomerase activity is absent in the ess1
ts
 strain, while tau appears toxic to the yeast cell. 
Although depletion of Pin1 activity clearly affects inclusion formation of protein tau expressed 
in yeast, future investigation is needed to identify the exact nature of these inclusions. Protein tau 
seems to accumulate at the periphery of the cell, which raises the question whether the inclusion 
formation can be induced by interaction of tau with membranous structures like lipid raft domains. 
There are several studies demonstrating the involvement of lipid rafts in AD but also other 
neurodegenerative disorders such as Parkinson’s disease and prion diseases, where they could serve 
as sites of protein processing [35-39]. An accumulation of phosphorylated tau was shown to occur in 
lipid rafts [40,41,42] and interestingly, in yeast, a fraction of tau is associated with these particular 
structures (unpublished data). Yet, a study by Maas and co-workers [43], highlights a high Tau1 and 
no AT180 immunoreactivity in case tau is associated with the plasma membrane, which does not 
apply for tau in the ess1
ts
 strain at restrictive temperature. Still, this would not necessarily rule out an 
interaction with lipid rafts since these are specialized microdomains of the plasma membrane, with 
other characteristics [44]. Alternatively, protein tau has been shown to interact with Golgi 
membranous structures to regulate their interaction with MT and this occurs upon phosphorylation of 
tau at e.g. Ser202 and PHF-1 sites, which overlap with the Tau1 and AD2 sites respectively [45]. In 
addition, accumulations of protein tau hyperphosphorylated at the AT8 site apparently induce 
fragmentation and subsequent loss of the Golgi-apparatus in cell lines and mice [46]. Therefore, 
interference with the Golgi system could also be a possible cause for cytotoxicity of tau in the ess1
ts
 
cells. 
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5. Conclusion 
In the past, S. cerevisiae has already been useful as a model organism to analyze the effect of 
phosphorylation, conformation and aggregation of tau [12,13,14]. We can conclude from this study 
that baker’s yeast can now also be chosen to investigate the effect of Pin1 activity on protein tau, to 
gain detailed insights in the Pin1-tau relationship. By expressing tau in the ess1
ts
 yeast strain, we are 
not only able to restate the effect of Pin1 on dephosphorylation of tau at multiple residues, we can 
also study the influence of the isomerase on the assembly properties of tau, which underscores the 
potential of using yeast as a model system for tau pathology. 
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